Search Within

Alison Moskowitz

Formats
  1. Meeting Abstract (195)
  2. Journal Article (124)
  3. Review (13)
  4. Research Letter (12)
  5. Editorial (5)
  6. Guidelines (3)
  7. Book Section (1)
  8. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (354)
  2. Department of Medicine (354)
  3. Hematologic Malignancies, Division of (354)
  4. Lymphoma (354)
  5. Population Sciences Research Program (231)
  6. Survivorship Research (147)

More Groups

People
  1. Steven Horwitz (231)
  2. Andrew Zelenetz (128)
  3. Paul Hamlin (117)
  4. Ariela Noy (115)
  5. Anita Kumar (104)
  6. Maria Palomba (101)

More People

Years
  1. 2025 (7)
  2. 2024 (36)
  3. 2023 (37)
  4. 2022 (20)
  5. 2021 (36)
  6. 2020 (30)

More Years

Publications
  1. Blood (150)
  2. Hematological Oncology (23)
  3. Journal of Clinical Oncology (21)
  4. Blood Advances (15)
  5. Journal of the American Academy of Dermatology (13)
  6. Leukemia and Lymphoma (13)

More Publications

Publishers
  1. American Society of Hematology (168)
  2. Wiley Blackwell (31)
  3. American Society of Clinical Oncology (24)
  4. Elsevier Inc. (21)
  5. Taylor & Francis Group (14)
  6. Mosby Elsevier (13)

More Publishers

Results (354)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
    Journal Article

    Epstein-Peterson, Z. D.; Drill, E.; Aypar, U.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamlin, P. A.; Ho, C.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma
    Research Letter

    Stuver, R.; Noy, A.; Vardhana, S. A.; Zelenetz, A. D.; Moskowitz, A. J.
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma involving osseous sites: Utility of response assessment by PET/CT and good long-term outcomes
    Journal Article

    Ghione, P.; Ahsanuddin, S.; Luttwak, E.; Varela, S. B.; Nakajima, R.; Michaud, L.; Gupta, K.; Navitski, A.; Straus, D.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Engraftment syndrome during autologous stem cell transplant in Hodgkin lymphoma patients treated with checkpoint inhibitors: A multi-center retrospective analysis
    Meeting Abstract

    Taranto, E.; Hwang, W. T.; Alfaro, M.; Surapaneni, A. S.; Gill, S. K.; Feldman, T.; Randall, M. P.; Spinner, M. A.; Furqan, F.; Shah, N. N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Efficacy of brentuximab vedotin maintenance therapy following autologous stem cell transplantation in patients with relapsed/refractory classical Hodgkin lymphoma with and without pre-transplant exposure to novel agents
    Meeting Abstract

    Falade, A. S.; Redd, R. A.; Shah, H.; Baron, K.; Iyengar, S.; Desai, S. H.; Ansell, S. M.; Micallef, I.; Nedved, A.; Ganesan, N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes for patients with classical Hodgkin lymphoma who relapse after autologous stem cell transplant in the era of novel therapies
    Meeting Abstract

    Stuver, R.; Drill, E.; Ganesan, N.; Baron, K.; Casper, E.; Chang, T.; Desai, S. H.; Falade, A. S.; Galasso, N.; Herrera, A. F.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of peri-transplant radiation on outcomes in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplant
    Meeting Abstract

    Baron, K.; Drill, E.; Ganesan, N.; Merryman, R. W.; Mei, M. G.; Stuver, R.; Desai, S. H.; Falade, A. S.; Iyengar, S.; Micallef, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with primary mediastinal B-cell lymphoma refractory or relapsed after frontline R-EPOCH chemotherapy
    Meeting Abstract

    Bakos, J.; Escribano Serrat, S.; Sawalha, Y.; Moskowitz, A.; Crawford, A.; Brooks, T. R.; Hill, B. T.; Falade, A. S.; Merryman, R. W.; Kamdar, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • AFM13 in combination with allogeneic natural killer cells (AB-101) in relapsed or refractory Hodgkin lymphoma and CD30+ peripheral T-cell lymphoma: A phase 2 study (LuminICE)
    Meeting Abstract

    Moskowitz, A.; Harstrick, A.; Emig, M.; Overesch, A.; Pinto, S.; Ravenstijn, P.; Schlüter, T.; Rubel, J.; Rebscher, H.; Graefe, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save